zintick

Vertex Pharmaceuticals VRTX

Vertex Pharmaceuticals Inc / MA · Nasdaq · Pharmaceutical Preparations

$553.15-1.03%close on Nov. 2, 2026 · volume 3.0M · Yahoo Finance

Price, last 50 sessions

$500.00$520.00$540.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 2, 2026 · high $558.88 · low $485.22 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 11 →
  • 8-KNov. 2, 2026, 4:05 p.m. ETView on SEC.govOur explainer

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedVertex Q3 2026 non-GAAP EPS of $4.76 and revenue of $3.44 billion in line with consensus; FY2026 revenue guidance raised to $13.15 to $13.25 billion, midpoint still below $13.28 billion consensus

  • 4Oct. 22, 2026, 4:10 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 4:09 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

    AI summary, unreviewedVertex Pharmaceuticals Adds Former Boston Scientific CFO Daniel Brennan to Board, Expanding Board to Eleven Members

  • 4Oct. 19, 2026, 4:23 p.m. ETView on SEC.gov
  • 4Oct. 19, 2026, 4:21 p.m. ETView on SEC.gov
  • 4Sept. 10, 2026, 4:31 p.m. ETView on SEC.gov
  • 4Sept. 1, 2026, 4:39 p.m. ETView on SEC.gov
  • 8-KSept. 1, 2026, 4:25 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers